CTOs on the Move

Miromatrix Medical

www.miromatrix.com

 
The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biological mesh for hernia repair – scientists around the globe are working with the Company’s technology and are taking critical steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. While our biological mesh development program has been conducted internally, our intent is for current and future products to be developed both at Miromatrix and in partnership with ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.miromatrix.com
  • 10399 West 70th Street
    Eden Prairie, MN USA 55344
  • Phone: 612.202.7026

Executives

Name Title Contact Details

Funding

Miromatrix Medical raised $23M on 09/01/2015
Miromatrix Medical raised $15.7M on 07/12/2018

Similar Companies

iScience Interventional

iScience Interventional is a Menlo Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sunoptic Technologies

Sunoptic Technologies is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ximedica

Ximedica is a full service ISO 13485 certified and FDA registered product development firm with an exclusive focus on medical products. With more than 25 years of experience developing medical devices, combination products and consumer healthcare products our client base spans the globe and ranges from start-ups to the world's largest OEMs.

Atlantic Imaging Group

Atlantic Imaging Group is a Cedar Knolls, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TELA Bio

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient`s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient`s natural healing response while minimizing long-term exposure to permanent synthetic materials.